Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect

This review discusses two distinct, yet related, mechanisms of sodium-glucose cotransporter 2 (SGLT2) inhibition: Calorie restriction mimicry (CRM) and pro-ketogenic effect, which may explain their cardiovascular benefits. We term these adaptive CRM and pro-ketogenic effects of SGLT2 inhibition, the...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Arpit Jain, Jignesh Ved, A G Unnikrishnan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=5;spage=725;epage=729;aulast=Kalra
_version_ 1811253922539503616
author Sanjay Kalra
Arpit Jain
Jignesh Ved
A G Unnikrishnan
author_facet Sanjay Kalra
Arpit Jain
Jignesh Ved
A G Unnikrishnan
author_sort Sanjay Kalra
collection DOAJ
description This review discusses two distinct, yet related, mechanisms of sodium-glucose cotransporter 2 (SGLT2) inhibition: Calorie restriction mimicry (CRM) and pro-ketogenic effect, which may explain their cardiovascular benefits. We term these adaptive CRM and pro-ketogenic effects of SGLT2 inhibition, the Robin Hood hypothesis. In English history, Robin Hood was a "good person," who stole from the rich and helped the poor. He supported redistribution of resources as he deemed fit for the common good. In a similar fashion, SGLT2 inhibition provides respite to the overloaded glucose metabolism while utilizing lipid stores for energy production.
first_indexed 2024-04-12T16:59:26Z
format Article
id doaj.art-20cf1f136578409c857ce20c89b6da5a
institution Directory Open Access Journal
issn 2230-8210
language English
last_indexed 2024-04-12T16:59:26Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-20cf1f136578409c857ce20c89b6da5a2022-12-22T03:24:07ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102016-01-0120572572910.4103/2230-8210.183826Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effectSanjay KalraArpit JainJignesh VedA G UnnikrishnanThis review discusses two distinct, yet related, mechanisms of sodium-glucose cotransporter 2 (SGLT2) inhibition: Calorie restriction mimicry (CRM) and pro-ketogenic effect, which may explain their cardiovascular benefits. We term these adaptive CRM and pro-ketogenic effects of SGLT2 inhibition, the Robin Hood hypothesis. In English history, Robin Hood was a "good person," who stole from the rich and helped the poor. He supported redistribution of resources as he deemed fit for the common good. In a similar fashion, SGLT2 inhibition provides respite to the overloaded glucose metabolism while utilizing lipid stores for energy production.http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=5;spage=725;epage=729;aulast=KalraCalorie restriction mimicry canagliflozincardiovascular outcomesdapagliflozindiabetesEMPA-REG outcomeempagliflozinketogenesisketogenic dietliraglutide
spellingShingle Sanjay Kalra
Arpit Jain
Jignesh Ved
A G Unnikrishnan
Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
Indian Journal of Endocrinology and Metabolism
Calorie restriction mimicry canagliflozin
cardiovascular outcomes
dapagliflozin
diabetes
EMPA-REG outcome
empagliflozin
ketogenesis
ketogenic diet
liraglutide
title Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
title_full Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
title_fullStr Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
title_full_unstemmed Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
title_short Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
title_sort sodium glucose cotransporter 2 inhibition and health benefits the robin hood effect
topic Calorie restriction mimicry canagliflozin
cardiovascular outcomes
dapagliflozin
diabetes
EMPA-REG outcome
empagliflozin
ketogenesis
ketogenic diet
liraglutide
url http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=5;spage=725;epage=729;aulast=Kalra
work_keys_str_mv AT sanjaykalra sodiumglucosecotransporter2inhibitionandhealthbenefitstherobinhoodeffect
AT arpitjain sodiumglucosecotransporter2inhibitionandhealthbenefitstherobinhoodeffect
AT jigneshved sodiumglucosecotransporter2inhibitionandhealthbenefitstherobinhoodeffect
AT agunnikrishnan sodiumglucosecotransporter2inhibitionandhealthbenefitstherobinhoodeffect